Dalbavancin in Bone and Joint Infections. Data from a retrospective study.

Dalbavancin is a lipoglycopeptide has a potent activity against Gram positive microorganisms, a long half-life (T1/2 160 – 240 h), a favorable safety profile, and a high concentration in bone (ref. 2). The aim of this study was to review the clinical characteristics, outcome, and adverse events observed in patients with bone and joint infections treated with dalbavancin. Methods